Thus, the microglia in BO co-cultures are impaired and may be a better model of EOAD, whereas our BO innate cultures treated with Aβs may be a more representative model of the more common later onset forms of AD, when the brain may still have a proportionally larger pool of functional microglia. The gene discussed is DDX41; the disease is Alzheimer disease.